Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter

Clinical Genitourinary Cancer 2026

View at publisher

Authors: Emanuele Crupi, Antonio Cigliola, Chiara Mercinelli, Michela Piacentini, Debora Serafin, Brigida A. Maiorano, Andrea Necchi

DOI: 10.1016/j.clgc.2026.102583

Cited by: 1

References: 14

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments HER2/EGFR in Cancer Research Wnt/β-catenin signaling in development and cancer

References 14